跳至主要内容
临床试验/ACTRN12618001950257
ACTRN12618001950257尚未招募不适用

Implantation and signal assessment of BioMonitor III in patients with suspected arrhythmias or symptoms suggestive of arrhythmic causes

BIOTRONIK Australia Pty. Ltd.0 个研究点目标入组 45 人开始时间: 2018年11月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Patient is at high risk of developing a clinically important cardiac arrhythmia; or
  • 2. Patient is undergoing investigation for symptoms such as palpitations, pre-syncope or syncope, that are suggestive of an underlying cardiac arrhythmia; or
  • 3. Patient is undergoing investigation for the detection of atrial fibrillation following cryptogenic stroke; or
  • 4. Patient is planned for AF ablative procedure or has already undergone an AF ablative procedure.
  • 5. Patient is able to understand the nature of study and has provided written informed consent
  • 6. Patient is willing and able to perform all follow up visits at the study site
  • 7. Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept

排除标准

  • 1. Patients implanted with ICD or pacemaker.
  • 2. Patient is pregnant or breast feeding.
  • 3. Patient is less than 18 years old.
  • 4. Patient is participating in another interventional clinical investigation
  • 5. Patient´s life-expectancy is less than 6 months.

研究者

发起方
BIOTRONIK Australia Pty. Ltd.

相似试验